Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1965 4
1970 1
1971 1
1973 1
1976 1
1982 1
1983 2
1984 1
1985 1
1986 2
1987 4
1988 3
1989 6
1990 1
1991 3
1992 4
1993 6
1994 2
1995 5
1996 1
1997 3
1998 7
1999 6
2000 6
2001 4
2002 2
2003 9
2004 16
2005 18
2006 17
2007 16
2008 13
2009 16
2010 12
2011 10
2012 18
2013 12
2014 16
2015 12
2016 16
2017 9
2018 7
2019 8
2020 17
2021 17
2022 19
2023 14
2024 14
2025 18
2026 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

369 results

Results by year

Filters applied: . Clear all
Page 1
Financial Navigation for People Newly Diagnosed With Cancer: Primary Outcomes From the Cancer Financial Experience Randomized Trial.
Henrikson NB, Anderson ML, Dickerson J, Petrik AF, Figueroa Gray M, Ewing JJ, Garcia R, Keast E, King DA, Locher B, Scrol A, Ramaprasan A, Rivelli JS, Schneider JL, Banegas MP. Henrikson NB, et al. Among authors: king da. JCO Oncol Pract. 2025 Dec;21(12):1817-1829. doi: 10.1200/OP-25-00874. Epub 2025 Oct 10. JCO Oncol Pract. 2025. PMID: 41070850 Free PMC article. Clinical Trial.
Author Correction: Targeting the SHOC2-RAS interaction in RAS-mutant cancers.
Hauseman ZJ, Stauffer F, Beyer KS, Mollé S, Cavicchioli E, Marchand JR, Fodor M, Viscomi J, Dhembi A, Katz S, Faggion B, Lanter M, Kerr G, Schildknecht D, Handl C, Maddalo D, Pissot Soldermann C, Brady J, Shrestha O, Nguyen Z, Leder L, Cremosnik G, Lopez Romero S, Hassiepen U, Stams T, Linder M, Galli GG, Guthy DA, King DA, Maira SM, Thoma CR, Ehmke V, Tordella L. Hauseman ZJ, et al. Among authors: king da. Nature. 2025 Jul;643(8072):E14. doi: 10.1038/s41586-025-09309-z. Nature. 2025. PMID: 40595365 Free PMC article. No abstract available.
Targeting the SHOC2-RAS interaction in RAS-mutant cancers.
Hauseman ZJ, Stauffer F, Beyer KS, Mollé S, Cavicchioli E, Marchand JR, Fodor M, Viscomi J, Dhembi A, Katz S, Faggion B, Lanter M, Kerr G, Schildknecht D, Handl C, Maddalo D, Pissot Soldermann C, Brady J, Shrestha O, Nguyen Z, Leder L, Cremosnik G, Lopez Romero S, Hassiepen U, Stams T, Linder M, Galli GG, Guthy DA, King DA, Maira SM, Thoma CR, Ehmke V, Tordella L. Hauseman ZJ, et al. Among authors: king da. Nature. 2025 Jun;642(8066):232-241. doi: 10.1038/s41586-025-08931-1. Epub 2025 May 7. Nature. 2025. PMID: 40335703 Free PMC article.
Shape-Evolving Structured Liquids.
Kim PY, Zhu S, Forth J, Xie G, King DA, Helms BA, Ashby PD, Omar AK, Russell TP. Kim PY, et al. Among authors: king da. Adv Mater. 2025 Jul;37(28):e2500804. doi: 10.1002/adma.202500804. Epub 2025 May 7. Adv Mater. 2025. PMID: 40331500 Free article.
An ultrasensitive method for detection of cell-free RNA.
Nesselbush MC, Luca BA, Jeon YJ, Jabara I, Meador CB, Garofalo A, Binkley MS, Hui AB, van 't Erve I, Xu N, Shi WY, Liu KJ, Sugio T, Kastelowitz N, Hamilton EG, Liu CL, Olsen M, Bonilla RF, Wang YP, Jiang A, Lau B, Eichholz J, Banwait M, Schroers-Martin J, Boegeholz J, King DA, Luikart H, Esfahani MS, Mehrmohamadi M, Stehr H, Raclin T, Tibshirani R, Khush K, Srinivas S, Yu H, Rogers AJ, Nair VS, Isbell JM, Li BT, Piotrowska Z, Sequist LV, Hata AN, Neal JW, Wakelee HA, Gentles AJ, Alizadeh AA, Diehn M. Nesselbush MC, et al. Among authors: king da. Nature. 2025 May;641(8063):759-768. doi: 10.1038/s41586-025-08834-1. Epub 2025 Apr 16. Nature. 2025. PMID: 40240612
Phase II trial of organ preservation program using short-course radiation and FOLFOXIRI for rectal cancer (SHORT-FOX): Two-Year primary outcome analysis.
Klebaner D, Brown E, Fisher GA, Shelton A, Johnson TP, Shaheen S, Chen C, Heestand G, Holden T, Bien J, King DA, Dawes AJ, Morris AM, Kirilcuk N, Kin C, Gahagan J, Sheth V, Ghanouni P, Richter S, Vitzthum L, Rahimy E, Chang DT, Pollom EL. Klebaner D, et al. Among authors: king da. Radiother Oncol. 2025 Jun;207:110884. doi: 10.1016/j.radonc.2025.110884. Epub 2025 Apr 8. Radiother Oncol. 2025. PMID: 40209856 Clinical Trial.
369 results